Advertisement
Screener

EXAGEN INC. (XGN) Cash Flow Breakdown

EXAGEN INC. Cash Flow Breakdown

Cash flow breakdown shows where EXAGEN INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $13.63M went out.
  • Fiscal year ended 2025-12-31: from investing, $626.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $24.43M came in.
  • Fiscal year ended 2025-12-31: change in cash, $10.18M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$13.63M-$626.00K-$19.70M$3.40M$40.74M*$10.18M
2024-12-31-$13.28M-$515.00K$0.00*$0.00-$663.00K*-$14.46M
2023-12-31-$14.46M-$804.00K-$10.00M$0.00$27.00K-$659.00K*-$25.90M
2022-12-31-$32.14M-$4.32M$0.00-$239.00K$0.00-$36.95M
2021-12-31-$20.27M-$2.42M$0.00$69.14M-$4.46M*$41.99M
2020-12-31-$14.08M-$455.00K$0.00-$14.64M
2019-12-31-$9.71M-$103.00K$0.00$4.00K$68.73M*$58.92M
2018-12-31-$9.30M-$199.00K$5.00M$0.00$6.43M*$1.92M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backStaff share taxNew shares soldNot split outChange in cash
2026-06-30$3.99M*-$543.00K*$0.00*
2026-03-31-$10.42M-$228.00K$295.00K-$10.71M
2025-12-31-$3.01M*-$35.00K*$0.00*-$38.00K*
2025-09-30$2.94M*-$275.00K*$0.00*-$15.34M*$18.29M*
2025-06-30-$2.88M*-$209.00K*$1.00K*$21.93M*
2025-03-31-$10.67M-$107.00K$198.00K-$10.84M
2024-12-31$363.00K*-$146.00K*$0.00*$0.00*
2024-09-30-$2.18M*-$147.00K*$0.00*$0.00*
2024-06-30-$2.43M*-$136.00K*$0.00*
2024-03-31-$9.04M-$86.00K$0.00-$9.23M
2023-12-31$8.35M*-$84.00K*$0.00*$0.00*$0.00*
2023-09-30-$2.91M*-$2.00K*$0.00*$0.00*$0.00*
2023-06-30-$10.15M*-$322.00K*$0.00*$0.00*-$10.24M*
2023-03-31-$9.75M-$396.00K$0.00$27.00K-$10.21M
2022-12-31-$5.73M*-$406.00K*$0.00*-$15.00K*$0.00*
2022-09-30-$6.68M*-$879.00K*$0.00*-$2.00K*$0.00*
2022-06-30-$11.15M*-$1.95M*-$107.00K*$0.00*
2022-03-31-$8.57M-$1.09M-$115.00K$0.00-$9.69M
2021-12-31-$6.05M*-$1.06M*$0.00*$0.00*
2021-09-30-$5.46M*-$475.00K*$0.00*$0.00*
2021-06-30-$4.45M*-$714.00K*$0.00*$0.00*
2021-03-31-$4.31M-$167.00K$0.00$69.14M-$4.06M*$60.60M
2020-12-31-$3.90M*-$5.00K*$0.00*
2020-09-30-$2.13M*-$213.00K*$0.00*
2020-06-30-$4.76M*-$153.00K*$0.00*
2020-03-31-$3.30M-$84.00K$0.00-$3.44M
2019-12-31-$3.93M*-$26.00K*$0.00*-$1.79M*
2019-09-30-$1.67M*-$2.00K*$0.00*$63.26M*
2019-06-30-$2.17M*$288.00K*$0.00*$3.79M*
2019-03-31-$1.95M-$363.00K$0.00$3.48M*$1.16M
2018-12-31-$1.87M*$929.00K*$8.72M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Freenome, Inc. (FRNM)United States$0.143B
BIODESIX INC (BDSX)United States$0.312B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45